Paid Clinical Trials in Westlake, OH
As of June 2026, 58 paid clinical trials are recruiting in Westlake, Ohio. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Westlake offers studies at sites including UH Seidman Cancer Center at Saint John Medical Center for conditions such as Ulcerative Colitis, Crohn's Disease, Recurrent Endometrial Carcinoma, Colitis, Ulcerative. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Westlake
Trials by drug in Westlake
Filter results
58 clinical trials
↓ Download CSVStudy of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Assessment of Non-Invasive Testing in Major Liver-Related Outcomes
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
ALTO-100 in Bipolar Disorder With Depression (BD-D)
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
About research studies in Westlake
Westlake has approximately 58 recruiting research studies across a wide range of therapeutic areas. Ohio is home to The Ohio State University Wexner Medical Center, Cleveland Clinic, Cincinnati Children's, and University Hospitals Cleveland Medical Center — collectively running clinical trials across every major therapeutic area.
Top Research Study Locations in Westlake
Researchers run research studies in Westlake, OH at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UH Seidman Cancer Center at Saint John Medical Center | Recurrent Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | 18 |
| UHHS-Westlake Medical Center | Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Breast Cancer | 7 |
| Gastro Intestinal Research Institute of Northern Ohio, LLC | Obesity or Overweight, Colitis, Ulcerative, Crohn's Disease | 4 |
| North Shore Gastroenterology Research | Ulcerative Colitis, Crohn's Disease | 3 |
| Gastro Intestinal Research Institute of Northern Ohio | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis, Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| CRIOH | Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease | 2 |
| Gastro Intestinal Research Institute of Northern Ohio LLC | Colitis, Ulcerative, Crohn Disease | 2 |
| Gastro Intestinal Research Institute of Northern Ohio, LLC. | Crohn's Disease, Ulcerative Colitis | 2 |
| Northshore Gastroenterology Research | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| Altimmune Clinical Study Site | Alcohol Liver Disease | 1 |
| Clinical Research Institute of Ohio, LLC | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Clinical Research Institute of Ohio, LLC (CRIOH) | MASH - Metabolic Dysfunction-Associated Steatohepatitis | 1 |
| Neurocrine Clinical Site | Major Depressive Disorder | 1 |
| NorthShore Gastroenterology Research, LLC | Crohn's Disease, Ulcerative Colitis | 1 |
| St. John Medical Center | Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer | 1 |
| UH St. John Health Center | Adhesive Capsulitis of the Shoulder, Frozen Shoulder | 1 |
| UH Westlake Health Center | Adhesive Capsulitis of the Shoulder, Frozen Shoulder | 1 |
| Univ Hosp Westlake | Lumbar Spinal Stenosis | 1 |
| University Hospitals Health System St John Medical Center | Lumbar Spinal Stenosis | 1 |
| University Hospitals St. John Medical Center | Cutaneous Melanoma, Stage II | 1 |
| Vanda Investigational Site | Bipolar I Disorder, Schizophrenia | 1 |
| Westlake Brain Health | Schizophrenia | 1 |
Active & Upcoming Studies in Westlake (2026)
Recruiting trials in Westlake grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (21 active studies)
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · Phase 3 · National Cancer Institute (NCI)
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
Diabetes & metabolic (7 active studies)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study · Phase 3 · Eli Lilly and Company
Mental health & behavior (4 active studies)
- Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) · Bristol-Myers Squibb
- ALTO-100 in Bipolar Disorder With Depression (BD-D) · Phase 2 · Alto Neuroscience
Cardiovascular (1 active study)
Common conditions studied in Westlake
- Ulcerative Colitis (5 active studies). Ulcerative colitis trials examine biologic therapies, S1P receptor modulators, and oral small molecules for steroid-sparing remission.
- Crohn's Disease (4 active studies). Recruiting Crohn's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Recurrent Endometrial Carcinoma (3 active studies). ENT (otolaryngology) trials evaluate new treatments for hearing loss, swallowing disorders, and head and neck cancers — covering pharmacologic, surgical, and rehabilitative approaches.
- Colitis, Ulcerative (2 active studies). Recruiting Colitis, Ulcerative studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Endometrial Clear Cell Adenocarcinoma (2 active studies). Recruiting Endometrial Clear Cell Adenocarcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Endometrial Dedifferentiated Carcinoma (2 active studies). ENT (otolaryngology) trials evaluate new treatments for hearing loss, swallowing disorders, and head and neck cancers — covering pharmacologic, surgical, and rehabilitative approaches.
Leading research sponsors in Westlake
- National Cancer Institute (NCI)
- NRG Oncology
- Eli Lilly and Company
- SWOG Cancer Research Network
- Boehringer Ingelheim
Local regulations and guidelines
Clinical trials in Ohio are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Ohio research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Westlake. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Westlake
Hipa.ai aggregates every recruiting study in Westlake from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Westlake?
There are approximately 58 recruiting clinical trials in Westlake, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Westlake pay participants?
Most recruiting trials in Westlake compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Westlake?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Westlake?
The most common conditions under active study in Westlake include Ulcerative Colitis (5), Crohn's Disease (4), Recurrent Endometrial Carcinoma (3), Colitis, Ulcerative (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Westlake?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Westlake on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Westlake?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Westlake?
Recruiting research sites in Westlake include UH Seidman Cancer Center at Saint John Medical Center, UHHS-Westlake Medical Center, Gastro Intestinal Research Institute of Northern Ohio, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Westlake right now?
The largest active categories in Westlake are Cancer & tumors (21), Diabetes & metabolic (7), Mental health & behavior (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.